Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012, Article ID 906017, 8 pages
http://dx.doi.org/10.1155/2012/906017
Research Article

Methylation and Expression of Retinoblastoma and Transforming Growth Factor- 𝜷 1 Genes in Epstein-Barr Virus-Associated and -Negative Gastric Carcinomas

1Department of Medical Microbiology, Qingdao University Medical College, 38 Dengzhou Road, Qingdao 266021, China
2Department of Central Laboratory, The Affiliated Hospital of Qingdao University Medical College, 19 Jiangsu Road, Qingdao 266003, China
3Department of Laboratory, The Affiliated Hospital of Qingdao University Medical College, Qingdao University, 19 Jiangsu Road, Qingdao 266003, China
4Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh PA 15213, USA

Received 25 May 2012; Revised 8 August 2012; Accepted 13 August 2012

Academic Editor: A. Castells

Copyright © 2012 Xia Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Correa, M. B. Piazuelo, and M. C. Camargo, “The future of gastric cancer prevention,” Gastric Cancer, vol. 7, no. 1, pp. 9–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Uozaki and M. Fukayama, “Epstein-Barr virus and gastric carcinoma—viral carcinogenesis through epigenetic mechanisms,” International Journal of Clinical and Experimental Pathology, vol. 1, no. 3, pp. 198–216, 2008. View at Google Scholar
  3. S. Imai, S. Koizumi, M. Sugiura et al., “Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 9131–9135, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Ushiku, J. M. Chong, H. Uozaki et al., “p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma,” International Journal of Cancer, vol. 120, no. 1, pp. 60–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Akiba, C. Koriyama, R. Herrera-Goepfert, and Y. Eizuru, “Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features,” Cancer Science, vol. 99, no. 2, pp. 195–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Lee, S. H. Kim, S. H. Han, J. S. An, E. S. Lee, and Y. S. Kim, “Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis,” Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 354–365, 2009. View at Publisher · View at Google Scholar
  7. M. Fukayama, R. Hino, and H. Uozaki, “Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma,” Cancer Science, vol. 99, no. 9, pp. 1726–1733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Taby and J. P. Issa, “Cancer epigenetics,” Cancer Journal for Clinicians, vol. 60, no. 6, pp. 376–392, 2010. View at Publisher · View at Google Scholar
  9. K. Sakuma, J. M. Chong, M. Sudo et al., “High-density methylation of p14ARF and P16INK4A in Epstein-Barr virus-associated gastric carcinoma,” International Journal of Cancer, vol. 112, no. 2, pp. 273–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sudo, J. M. Chong, K. Sakuma et al., “Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma,” International Journal of Cancer, vol. 109, no. 2, pp. 194–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. H. Kang, S. Lee, W. H. Kim et al., “Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma,” American Journal of Pathology, vol. 160, no. 3, pp. 787–794, 2002. View at Google Scholar · View at Scopus
  12. K. G. Wiman, “The retinoblastoma gene: role in cell cycle control and cell differentiation,” FASEB Journal, vol. 7, no. 10, pp. 841–845, 1993. View at Google Scholar · View at Scopus
  13. R. J. Akhurst and R. Derynck, “TGF-β signaling in cancer—a double-edged sword,” Trends in Cell Biology, vol. 11, no. 11, pp. S44–S51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Attisano and J. L. Wrana, “Signal transduction by the TGF-β superfamily,” Science, vol. 296, no. 5573, pp. 1646–1647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lutz and P. Knaus, “Integration of the TGF-β pathway into the cellular signalling network,” Cellular Signalling, vol. 14, no. 12, pp. 977–988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Huang, S. M. Leal, C. L. Chen, I. H. Liu, and J. S. Huang, “Cellular growth inhibition by TGF-beta1 involves IRS proteins,” FEBS Letters, vol. 565, no. 1–3, pp. 117–121, 2004. View at Publisher · View at Google Scholar
  17. M. Fukuda, W. Kurosaki, K. Yanagihara, H. Kuratsune, and T. Sairenji, “A mechanism in epstein-barr virus oncogenesis: inhibition of transforming growth factor-β1-mediated induction of MAPK/p21 by LMP1,” Virology, vol. 302, no. 2, pp. 310–320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Fukuda, K. Ikuta, K. Yanagihara et al., “Effect of transforming growth factor-β1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines,” Virology, vol. 288, no. 1, pp. 109–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Imai, S. Koizumi, M. Sugiura et al., “Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 9131–9135, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Cito, F. Pentimalli, I. Forte, E. Mattioli, and A. Giordano, “Rb family proteins in gastric cancer,” Oncology Reports, vol. 24, no. 6, pp. 1411–1418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Ananiev, M. Gulubova, G. Tchernev et al., “Relation between transforming growth factor-beta1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers,” Wiener Klinische Wochenschrift, vol. 123, no. 21-22, pp. 668–673, 2011. View at Publisher · View at Google Scholar
  22. S. A. Galetsky, V. V. Tsvetnov, C. E. Land et al., “Epstein-Barr-Virus-associated gastric cancer in Russia,” International Journal of Cancer, vol. 73, no. 6, pp. 786–789, 1997. View at Google Scholar · View at Scopus
  23. M. S. Chang, H. S. Lee, C. W. Kim, Y. I. Kim, and W. H. Kim, “Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea,” Pathology Research and Practice, vol. 197, no. 6, pp. 395–400, 2001. View at Google Scholar · View at Scopus
  24. P. Mukherjee, S. L. Winter, and M. G. Alexandrow, “Cell cycle arrest by transforming growth factor β1 near G 1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction,” Molecular and Cellular Biology, vol. 30, no. 3, pp. 845–856, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, K. Kanai, Y. Satoh, B. Luo, and T. Sairenji, “Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from eastern China and Japan,” Intervirology, vol. 50, no. 3, pp. 229–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Khaled, A. A. Bahnassy, A. A. Raafat, A. R. N. Zekri, M. S. Madboul, and N. M. Mokhtar, “Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer,” BMC Cancer, vol. 9, p. 32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Valkov, S. W. Sorbye, T. K. Kilvaer et al., “The prognostic impact of TGF-β1, fascin, NF-κb and PKC-ζ expression in soft tissue sarcomas,” PLoS ONE, vol. 6, no. 3, Article ID e17507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Tao, H. Huang, T. M. Geiman et al., “Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells,” Human Molecular Genetics, vol. 11, no. 18, pp. 2091–2102, 2002. View at Google Scholar · View at Scopus
  29. T. Osawa, J. M. Chong, M. Sudo et al., “Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma,” Japanese Journal of Cancer Research, vol. 93, no. 11, pp. 1195–1200, 2002. View at Google Scholar · View at Scopus
  30. Y. F. Zhao, Y. G. Zhang, X. X. Tian, J. Du, and J. Zheng, “Aberrant methylation of multiple genes in gastric carcinomas,” International Journal of Surgical Pathology, vol. 15, no. 3, pp. 242–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Y. M. Tse, H. K. Ng, K. W. Lo et al., “Analysis of cell cycle regulators: p161NK4A, pRb, and CDK4 in low- and high-grade meningiomas,” Human Pathology, vol. 29, no. 11, pp. 1200–1207, 1998. View at Google Scholar · View at Scopus
  32. C. Dahl and P. Guldberg, “DNA methylation analysis techniques,” Biogerontology, vol. 4, no. 4, pp. 233–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. L. H. Kim, S. C. Peh, and S. Poppema, “Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death,” Human Pathology, vol. 37, no. 1, pp. 92–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Xu, J. Menezes, U. Prasad, and A. Ahmad, “Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients,” International Journal of Cancer, vol. 8484, no. 4, pp. 396–399, 1999. View at Google Scholar
  35. K. Vagenas, C. Spyropoulos, V. Gavala, and A. C. Tsamandas, “TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival,” Journal of Surgical Research, vol. 139, no. 2, pp. 182–188, 2007. View at Publisher · View at Google Scholar
  36. H. Saito, S. Tsujitani, S. Oka et al., “The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma,” Cancer, vol. 86, no. 8, pp. 1455–1462, 1999. View at Publisher · View at Google Scholar
  37. Y. Maehara, Y. Kakeji, A. Kabashima et al., “Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma,” Journal of Clinical Oncology, vol. 17, no. 2, pp. 607–614, 1999. View at Google Scholar · View at Scopus
  38. G. Kouraklis, I. E. Katsoulis, S. Theocharis et al., “Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?” Digestive Diseases and Sciences, vol. 54, no. 5, pp. 1015–1020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. S. Song, I. H. Kim, S. S. Sohn, K. Y. Kwon, and W. S. Lee, “Prognostic significance of immunohistochemical expression of p53 and retinoblastoma gene protein (pRB) in curatively resected gastric cancer,” Korean Journal of Internal Medicine, vol. 20, no. 1, pp. 1–7, 2005. View at Google Scholar · View at Scopus
  40. R. M. Feakins, C. D. Nickols, H. Bidd, and S. J. Walton, “Abnormal expression of pRb, p16, and Cyclin D1 in Gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival,” Human Pathology, vol. 34, no. 12, pp. 1276–1282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. N. H. Chou, H. C. Chen, N. S. Chou, P. I. Hsu, and H. H. Tseng, “Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma,” World Journal of Gastroenterology, vol. 12, no. 44, pp. 7188–7191, 2006. View at Google Scholar · View at Scopus
  42. I. Kishimoto, H. Mitomi, Y. Ohkura, H. Kanazawa, N. Fukui, and M. Watanabe, “Abnormal expression of p16INK4a, cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas,” Journal of Surgical Oncology, vol. 98, no. 1, pp. 60–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. X. S. He, Y. H. Rong, Q. Su et al., “Expression of p16 gene and Rb protein in gastric carcinoma and their chinicopathological significance,” World Journal of Gastroenterology, vol. 11, no. 15, pp. 2218–2223, 2005. View at Google Scholar · View at Scopus
  44. V. Zolota, A. Batistatou, A. C. Tsamandas, G. Iliopoulos, C. D. Scopa, and D. S. Bonikos, “Immunohistochemical expression of TGF-β1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study,” International Journal of Gastrointestinal Cancer, vol. 32, no. 2-3, pp. 83–89, 2002. View at Google Scholar · View at Scopus